Oakland, California--(Newsfile Corp. - January 11, 2021) - The Magic Mushroom Company (OTCP Pink: MINE) specializing in growing, research, production and distribution of psilocybin mushrooms, announced today that Paul Hoonjan has been appointed as its new President.
KCSA Communications hosts an investment conference featuring Rick Doblin (MAPS) as a keynote speaker.
Tony White called his therapy session powered by magic mushrooms “a good trip.”
NEW YORK, Jan. 7, 2021 /PRNewswire/ -- Among the popular fields of study for biotech companies in recent years are gene editing, tissue engineering and regeneration, nanobiotechnology and others.
MindMed closes on a CAD$92.1 million financing from what was originally a $50 million offering. Total cash on hand increases to US$144.4 million.
Psychedelic Stock Watch connects the dots regarding Mind Cure's clinic launch and latest product development news.
PALM BEACH, Fla., Jan. 6, 2021 /PRNewswire/ -- In the few places where cannabis is legal, it can be incredibly lucrative. In 2019, the nascent worldwide cannabis sector pumped out approximately $15 billion in sales.
Cybin Corp updates investors on its IP development
Numinus announces a product development agreement with Optimi Health Corp.
While the world waited breathlessly this fall for anything resembling definitive results from the Nov. 3 presidential election, one early winner seemed clear: drugs.
Mind Cure's iSTRYM digital therapeutics platform is designed to provide real-time data regarding patient care.
During the November election, Oregon voters approved a measure allowing licensed centers to provide psilocybin, the substance found in “magic mushrooms,” to help treat people experiencing a range of mental health issues.
